These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12913983)

  • 21. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 22. CIBIS III trial: Bisoprolol treatment for CHF leads to 46% reduction in sudden death after one year.
    Cardiovasc J S Afr; 2006; 17(5):278. PubMed ID: 17117242
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Karpov IuA
    Kardiologiia; 2005; 45(12):87-92. PubMed ID: 16353053
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of long-term therapy with contemporary drugs on diastolic cardiac function in patients with chronic heart failure].
    Belousov IuB; Upnitskiĭ AA; Khanina NIu
    Kardiologiia; 2005; 45(2):26-32. PubMed ID: 15798702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapeutic strategy in heart failure.
    Dominiak P
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S2-6. PubMed ID: 12227721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blockade as first-line therapy in the elderly heart failure patient--the proper approach or asking for trouble?
    Remme WJ
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):347-50. PubMed ID: 18679783
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
    Cleland JG
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():297-303. PubMed ID: 9211024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in the pharmacotherapy of cardiac failure.
    Campbell TJ
    Med J Aust; 1992 Sep; 157(5):292-4. PubMed ID: 1359389
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
    Dobre D; van Veldhuisen DJ; Goulder MA; Krum H; Willenheimer R
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):399-405. PubMed ID: 18528751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
    Kanopskiĭ SG; Staritskiĭ AG; Bozhko AA
    Kardiologiia; 2004; 44(10):13-8. PubMed ID: 15477784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical assessment of metabolic effects of antihypertensive therapy].
    Tkacheva ON; Shumbutova AIu; Novikova IM; Samsonenko NS; Guseva KIu
    Kardiologiia; 2008; 48(3):34-8. PubMed ID: 18429754
    [No Abstract]   [Full Text] [Related]  

  • 34. Reverse remodeling in heart failure with intensification of vasodilator therapy.
    Levine TB; Levine AB; Keteyian SJ; Narins B; Lesch M
    Clin Cardiol; 1997 Aug; 20(8):697-702. PubMed ID: 9259162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in parameters of coagulation system after treatment of chronic heart failure with β-adrenoblockers, angiotensin-converting enzyme inhibitors, calcium antagonists, diuretics, anticoagulants, antiagregants, cardiac glycosides, and physical exercise].
    Mongirdienė A
    Medicina (Kaunas); 2011; 47(4):238-43. PubMed ID: 21829057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of depressive disorders in hypertensive disease and possibilities of their correction: assessment of the effect of tianeptine].
    Kirichenko AA; Ebzeeva EIu
    Kardiologiia; 2002; 42(10):36-40. PubMed ID: 12494055
    [No Abstract]   [Full Text] [Related]  

  • 37. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
    MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
    Tereshchenko SN; Aleksandriia LG; Moiseev VS
    Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051
    [No Abstract]   [Full Text] [Related]  

  • 39. [Why heart failure clinics?].
    Hülsmann M; Pacher R
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):819-21. PubMed ID: 12503472
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical trials on heart failure].
    Cosín Aguilar J; Hernándiz Martínez A
    Rev Esp Cardiol; 2001; 54 Suppl 1():22-31. PubMed ID: 11535185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.